Market Analysis — UVA TRANSITIONAL CARE HOSPITAL
VA market | 3 hospitals | HHI: 8,782 (Concentrated)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
3
Hospitals in Market
240
Total Beds
$0.4B
Market Revenue
Concentrated
HHI: 8,782
None
Moat Rating (1/10)
#3
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantageweak
Switching Costslow
Market Share0.2%
Top 3 Concentration100.0%
Network Density1.25
Margin vs Market+1.4%
Bed Util vs Market-39.5%
What This Means
This hospital has a none moat — no moat — commoditized market position, pricing power limited. The VA market is highly concentrated — few dominant players, potential antitrust concerns (HHI: 8,782).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full VA market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| SENTARA MARTHA JEFFERSON HOSPITAL | 150 | $362M | 93.5% | 62.5% |
| UVA ENCOMPASS HEALTH REHABILITATION | 50 | $24M | 6.2% | 20.8% |
Regional Payer Mix
■ Medicare 44%■ Medicaid 1%■ Commercial 55%